Geode Capital Management
AMPE

Geode Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Geode Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,474
Closed -$99K – 5077
2022
Q3 		$99K Hold
5,474
– – ﹤0.01% 4583
2022
Q2 		$275K Sell
5,474
-4,235
-44% -$315K ﹤0.01% 4079
2022
Q1 		$1.37M Sell
9,709
-543
-5% -$79.3K ﹤0.01% 3464
2021
Q4 		$1.75M Sell
10,252
-124
-1% -$46.2K ﹤0.01% 3431
2021
Q3 		$5.17M Buy
10,376
+439
+4% +$204K ﹤0.01% 2899
2021
Q2 		$4.98M Buy
9,937
+5,145
+107% +$2.76M ﹤0.01% 2914
2021
Q1 		$2.43M Buy
4,792
+667
+16% +$344K ﹤0.01% 3162
2020
Q4 		$1.97M Buy
4,125
+1,132
+38% +$371K ﹤0.01% 3096
2020
Q3 		$859K Buy
2,993
+286
+11% +$70.9K ﹤0.01% 3265
2020
Q2 		$517K Buy
2,707
+336
+14% +$55.9K ﹤0.01% 3367
2020
Q1 		$295K Buy
2,371
+12
+0.5% +$2.17K ﹤0.01% 3434
2019
Q4 		$412K Hold
2,359
– – ﹤0.01% 3571
2019
Q3 		$354K Buy
2,359
+425
+22% +$56.6K ﹤0.01% 3590
2019
Q2 		$224K Sell
1,934
-1,230
-39% -$195K ﹤0.01% 3761
2019
Q1 		$533K Buy
3,164
+285
+10% +$48.8K ﹤0.01% 3417
2018
Q4 		$340K Buy
2,879
+122
+4% +$18.7K ﹤0.01% 3504
2018
Q3 		$420K Buy
2,757
+450
+20% +$188K ﹤0.01% 3535
2018
Q2 		$1.52M Buy
2,307
+682
+42% +$510K ﹤0.01% 3003
2018
Q1 		$1.66M Hold
1,625
– – ﹤0.01% 2865
2017
Q4 		$1.98M Buy
1,625
+820
+102% +$386K ﹤0.01% 2753
2017
Q3 		$147K Sell
805
-8
-1% -$1.27K ﹤0.01% 3737
2017
Q2 		$127K Sell
813
-231
-22% -$46.7K ﹤0.01% 3790
2017
Q1 		$250K Buy
1,044
+28
+3% +$7.53K ﹤0.01% 3578
2016
Q4 		$274K Buy
1,016
+10
+1% +$2.38K ﹤0.01% 3494
2016
Q3 		$223K Buy
1,006
+28
+3% +$7.85K ﹤0.01% 3559
2016
Q2 		$378K Buy
978
+220
+29% +$240K ﹤0.01% 3335
2016
Q1 		$511 Hold
758
– – ﹤0.01% 3227
2015
Q4 		$796K Hold
758
– – ﹤0.01% 3032
2015
Q3 		$657K Buy
758
+73
+11% +$61.1K ﹤0.01% 3092
2015
Q2 		$487K Sell
685
-107
-14% -$114K ﹤0.01% 3216
2015
Q1 		$1.79M Buy
792
+13
+2% +$22.2K ﹤0.01% 2514
2014
Q4 		$801K Hold
779
– – ﹤0.01% 2966
2014
Q3 		$825K Hold
779
– – ﹤0.01% 2901
2014
Q2 		$1.95M Buy
779
+124
+19% +$253K ﹤0.01% 2380
2014
Q1 		$1.25M Buy
655
+155
+31% +$367K ﹤0.01% 2640
2013
Q4 		$1.07M Buy
500
+80
+19% +$189K ﹤0.01% 2669
2013
Q3 		$944K Buy
420
+71
+20% +$137K ﹤0.01% 2625
2013
Q2 		$604K Buy
+349
New +$554K ﹤0.01% 2766

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Geode Capital Management's AMPE Position: Q4 2022 in Review

Geode Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 5,474 shares — an estimated $99K sold.

Geode Capital Management first reported a position in AMPE in Q2 2013 and held it in 38 quarters. The position peaked at $5.17M in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Geode Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Geode Capital Management sold 5,474 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $99K.
  • Geode Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 38 quarters.
  • Geode Capital Management's Ampio Pharmaceuticals Inc. position peaked at $5.17M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.